Knowledge Distillery

Perceived stress and social support in a large population of people with multiple sclerosis recruited online through COVID 19 pandemic.

In this study recently published in the New England Journal of Medicine, the authors conducted a phase 1, dose-escalation, open-label trial including…

SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients

The objective of this study was to review the literature and provide a summary of COVID-19-related neurologic and neuro-ophthalmic complications.

Severe COVID-19-related encephalitis can respond to immunotherapy

In this controlled, open-label trial recently published in the New England Journal of Medicine, the authors randomly assigned patients who were…

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

The goal of this study is to update the pooled prevalence of COVID-19 infection in patients with Parkinson's disease.

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome

Members of the EAN Scientific Panel on Infectious Diseases have recently published a systematic review of neurological manifestations of SARS‐CoV‐2…

COVID-19 and emerging spinal cord complications: A systematic review

This overview attempts to give a thorough insight into SARS-CoV-2 neurological infection and highlights the possible mechanisms leading to the…